[1P] F. Disorders of the Nervous System 1

[1P-093] Development of therapeutic drugs for schizophrenia targeting PPAR alpha

*Fumiko Yoshimachi^1,2, Motoko Maekawa², Tetsuo Ohnishi³, Yuji Owada² (1. Dept Med, Univ of Tohoku, Sendai, Japan, 2. Dept of Organ Anatomy, Grad Sch Med, Univ of Tohoku, Sendai, Japan, 3. Medical Research Inst, Tokyo Medical and Dental Univ, Tokyo, Japan)

Keywords:Peroxisome proliferator-activated receptor α (PPARα), Therapeutic target, Synaptogenesis, Gene expression